Par Pharmaceutical Companies
Par Pharmaceutical Companies: annual report for the year ended Dec 31, 2009
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0000878088-10-000019
- Document
- 10-K
- Exhibit 10.6
- Terms of restricted shares award
- Exhibit 10.6
- Terms of stock option
- Exhibit 10.6
- Terms of restricted stock unit award
- Exhibit 10.11
- Amendment to lease
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2834) and public float not reported.
